Additionally, METTL3 positively correlated with both PD‐L1 and CD47 in HCC (Figure 3B), and the downregulation of METTL3 significantly decreased PD‐L1 and CD47 expressions in HepG2 cells (Figure 3C). This evidence concerns the gene METTL3 and hepatocellular carcinoma.